Exane Derivatives Portfolio Holdings

Exane Derivatives

  • $157 Million
  • Q2 2022

Exane Derivatives has filed its 13F form on July 12, 2022 for Q2 2022 where it was disclosed a total value porftolio of $157 Million distributed in 758 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $8.79M, Microsoft Corp with a value of $6.17M, Merck & Co., Inc. with a value of $5.92M, Cameco Corp with a value of $5.21M, and Ishares Inc Msci Global Select with a value of $3.52M.

Examining the 13F form we can see an decrease of $167M in the current position value, from $323M to 157M. Also it can be appreciated an additional of 57 stocks purchases and 316 closed positions.

Below you can find more details about Exane Derivatives portfolio as well as his latest detailed transactions.

Portfolio value $157 Million
ETFs: $28.2 Million
Technology: $25.8 Million
Healthcare: $20.9 Million
Energy: $19.3 Million
Industrials: $11.4 Million
Consumer Defensive: $10.7 Million
Financial Services: $10.4 Million
Consumer Cyclical: $10.2 Million
Other: $19.7 Million

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$12.2B
$147,000 0.09% of portfolio
1,098
Q2 2022 Added 1.48%
$5.28B
$122,000 0.08% of portfolio
1,707
Q1 2022 Reduced 10.91%
$6.32B
$121,000 0.08% of portfolio
3,478
Q2 2022 Reduced 89.76%
$0
$124,000 0.08% of portfolio
2,564
Q2 2022 Reduced 37.89%
$7.39B
$133,000 0.08% of portfolio
1,137
Q2 2022 Added 22,640.0%
$27.4B
$119,000 0.08% of portfolio
799
Q2 2022 Added 13.49%
$12.2B
$122,000 0.08% of portfolio
1,473
Q2 2022 Reduced 22.02%
$38.7B
$129,000 0.08% of portfolio
2,321
Q2 2022 Reduced 14.48%
$3.08B
$123,000 0.08% of portfolio
1,539
Q2 2022 Reduced 81.26%
$2.98B
$131,000 0.08% of portfolio
7,777
Q2 2022 Added 12,443.55%
$7.58B
$102,000 0.07% of portfolio
4,724
Q2 2022 Reduced 55.77%
$30.4B
$110,000 0.07% of portfolio
1,857
Q2 2022 Reduced 77.3%
$13B
$105,000 0.07% of portfolio
1,084
Q2 2022 Added 36,033.33%
$1.2B
$108,000 0.07% of portfolio
3,143
Q1 2022 Added 39.26%
$14.4B
$115,000 0.07% of portfolio
3,024
Q2 2022 Reduced 77.17%
$7.58B
$111,000 0.07% of portfolio
1,444
Q2 2022 Added 3.0%
$989M
$107,000 0.07% of portfolio
2,776
Q2 2022 Added 2.85%
$36.6B
$106,000 0.07% of portfolio
490
Q1 2022 Reduced 7.89%
$5.48B
$107,000 0.07% of portfolio
1,197
Q2 2022 Reduced 40.36%
$41.1B
$116,000 0.07% of portfolio
960
Q2 2022 Reduced 87.29%
$582M
$110,000 0.07% of portfolio
10,338
Q1 2022 Reduced 1.59%
$55.5B
$97,000 0.06% of portfolio
3,337
Q2 2022 Reduced 92.03%
$710M
$92,000 0.06% of portfolio
9,496
Q1 2022 Reduced 7.87%
$292M
$94,000 0.06% of portfolio
11,141
Q2 2022 Added 89.67%
$8.01B
$96,000 0.06% of portfolio
1,309
Q2 2022 Reduced 13.54%
$1.28B
$87,000 0.06% of portfolio
8,683
Q1 2022 Added 15.76%
$60.5B
$99,000 0.06% of portfolio
1,067
Q2 2022 Reduced 77.9%
$128B
$98,000 0.06% of portfolio
230
Q2 2022 Added 0.44%
$1.56B
$96,000 0.06% of portfolio
4,246
Q2 2022 Added 2.17%
$33.4B
$101,000 0.06% of portfolio
1,130
Q2 2022 Reduced 57.31%
$0
$93,000 0.06% of portfolio
740
Q1 2022 Reduced 7.85%
$2.14B
$88,000 0.06% of portfolio
2,279
Q2 2022 Reduced 10.49%
$48.4B
$99,000 0.06% of portfolio
242
Q2 2022 Reduced 63.05%
$3.89B
$87,000 0.06% of portfolio
2,279
Q2 2022 Added 7,496.67%
$238M
$84,000 0.05% of portfolio
4,155
Q1 2022 Reduced 26.85%
$0
$81,000 0.05% of portfolio
1,017
Q2 2022 Added 75.95%
$55.9B
$85,000 0.05% of portfolio
174
Q2 2022 Added 4.82%
$405B
$73,000 0.05% of portfolio
423
Q2 2022 Reduced 51.21%
$6.13B
$74,000 0.05% of portfolio
6,791
Q2 2022 Reduced 1.95%
$12.4B
$84,000 0.05% of portfolio
303
Q2 2022 Reduced 64.77%
$210B
$73,000 0.05% of portfolio
255
Q2 2022 Reduced 87.8%
$16.3B
$71,000 0.05% of portfolio
537
Q2 2022 Reduced 13.11%
$310M
$80,000 0.05% of portfolio
14,377
Q2 2022 New
$3B
$83,000 0.05% of portfolio
4,286
Q2 2022 Reduced 11.0%
$56.5B
$86,000 0.05% of portfolio
185
Q2 2022 Reduced 2.63%
$129M
$78,000 0.05% of portfolio
62,153
Q2 2022 New
$28.4M
$86,000 0.05% of portfolio
219
Q2 2022 Reduced 9.88%
$2.45B
$72,000 0.05% of portfolio
3,999
Q2 2022 Reduced 4.01%
$78.7M
$83,000 0.05% of portfolio
465
Q2 2022 Reduced 72.4%

Summary

  • Portfolio
  • No. of Stocks 758
  • Current Value $157 Million
  • Prior Value $323 Million
  • Filing
  • Period Q2 2022
  • Filing Date July 12, 2022
  • Form Type 13F-HR
  • Activity in Q2 2022
  • New Purchases 57 stocks
  • Additional Purchases 90 stocks
  • Sold out of 316 stocks
  • Reduced holdings in 353 stocks
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email